Rumored Buzz on Healthcare News
FTC sues significant pharmacy advantage managers more than insulin prices The agency introduced action in opposition to Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the checklist price of existence-conserving insulin medications.This plan aligns with All tho